The pediatric orthopedic implants market has seen considerable growth due to a variety of factors.
•The market for pediatric orthopedic implants has seen significant growth in recent years. The upsurge is expected to continue as projections state that the market value will increase from $1.84 billion in 2024 to $2.02 billion in 2025, with a compound annual growth rate (CAGR) of 9.6%.
This upward trend during the historic period is likely linked to improvements in pediatric orthopedic surgical methods, an increasing number of orthopedic issues among children, an increase in sports injuries in the pediatric population, a rise in awareness and education, and the growth of pediatric subspecialization in the field of orthopedics.
The pediatric orthopedic implants market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, substantial growth is expected for the pediatric orthopedic implants market, with a projected increase to $2.98 billion in 2029 with a compound annual growth rate (CAGR) of 10.3%.
Factors catalyzing this growth within the forecast period include the rise in personalized and customized implants, a heightened emphasis on minimally invasive procedures, an increase in pediatric musculoskeletal disorder cases, and a surge in pediatric trauma incidents. Key trends for the forecast period encompass cooperative efforts for research and development, advancements in implant designs, progress in imaging technologies, innovative developments in implant materials, and the use of telehealth in pediatric orthopedic care.
The anticipated increase in the population of children is likely to spur the expansion of the pediatric orthopedic implants market in the future. Children are defined as young individuals who haven't yet reached maturity and are in the early stages of their growth. Pediatric orthopedic implants offer a range of benefits to patients, including alleviation of pain, reduction of swelling, inflammation relief, and aid in limb mobility. For instance, a report published by the Forum on Child and Family Statistics, an assemblage of 23 Federal government entities engaged in child and family-related research and activities, stated that the United States had 72.5 million children in 2022, marking a reduction of 0.4 million from 2021. However, the child population is anticipated to escalate to 78.2 million by 2050. As a result, the increasing child population is a significant driver of the pediatric orthopedic implants market.
The pediatric orthopedic implants market covered in this report is segmented –
1) By Type: Hip Implants, Spine Implants, Knee Implants, Dental Implants, Craniomaxillofacial Implants, Other Types
2) By Application: Birth Deformities, Limping, Broken Bones, Bone And Joint Infection, Spinal Deformities, Other Applications
3) By End User: Hospitals, Pediatric Clinics, Other End Users
Subsegments:
1) By Hip Implants: Total Hip Replacement Implants, Partial Hip Replacement Implants, Hip Stabilization Implants
2) By Spine Implants: Spinal Fusion Implants, Growth-Friendly Spinal Implants, Scoliosis Correction Implants
3) By Knee Implants: Total Knee Replacement Implants, Partial Knee Replacement Implants, Knee Reconstruction Implants
4) By Dental Implants: Endosteal Implants, Subperiosteal Implants, Mini Dental Implants
5) By Craniomaxillofacial Implants: Cranial Implants, Facial Reconstruction Implants, Mandibular Implants
6) By Other Types: Upper Extremity Implants, Lower Extremity Implants, Custom Pediatric Implants
One prominent trend garnering attention in the pediatric orthopedic implants market is product innovation. To maintain their standing in the market, leading companies in the pediatric orthopedic implant domain are concentrating on generating new products. Take, for example, OrthoPediatrics, an American bioscience firm, which introduced its RESPONSE Rib and Pelvic Fixation System in March 2024. This system was specifically crafted to assist children diagnosed with Early Onset Scoliosis (EOS), particularly those at possible risk of Thoracic Insufficiency Syndrome. The RESPONSE product line, including this system, offers a wide variety of implants and instruments, all designed for rib and pelvic fixation, thus facilitating personalized medical care for young patients. The overall objective of this launch is to enhance patient results by providing surgeons with a comprehensive array of tools capable of managing scoliosis of different severities effectively.
Major companies operating in the pediatric orthopedic implants market include:
• Medtronic Plc.
• Stryker Corporation
• B. Braun SE
• DePuy Synthes
• Zimmer Biomet
• Smith & Nephew Plc.
• Arthrex Inc.
• NuVasive Inc.
• DJO Global
• CONMED Corporation
• Globus Medical
• Orthofix Medical Inc.
• Corin Group
• OrthoPediatrics Corporation
• SI-BONE Inc.
• FH Orthopedics
• Baumer S.A.
• Acumed
• Merete Medical GmbH
• JRI Orthopaedics Limited
• GPC Medical Ltd.
• Samay Surgical
• Auxein Inc.
• Wishbone Medical Inc.
• Waldemar Link GmbH & Co. KG
• Implantcast GmbH
• Bioretec Ltd.
• Suhradam Ortho
• Vast Ortho.
North America was the largest region in the pediatric orthopedic implants market in 2024. The regions covered in the pediatric orthopedic implants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa